India's only Gem in Pharma - Syngene International Ltd | Stock Research |

#syngeneinternational #pharmastocks #stockstobuy
Ever wondered how medical or pharmaceutical companies develop a new drug? And how long does it take for them to bring it to the market? No idea.. naa..

Well, the journey to create a medical drug is a complex one, with multiple stages involved. On average, it can take around 10 to 15 years for a new drug to go from discovery to being available for patients.

Syngene which is a leading contract research organization (CRO), supports R&D programmes of global innovative companies. In fact Syngene is a subsidiary of its group company Biocon. And Biocon is among the world’s Top 15 bio-manufacturing companies.

Watch full video to know the business expansion and future outlook.
--------------------------------------------------------------------------------------
For Investment Queries : https://www.pawealth.in/
--------------------------------------------------------------------------------------
For Blog:
Click : https://blog.pawealth.in/2023/06/17/s...
--------------------------------------------------------------------------------------

Connect with us for Regular updates

Instagram :   / pawealthh  
Facebook :   / pawealth  
Twitter :   / pawealthh  
LinkedIn :   / pawealth  

--------------------------------------------------------------------------------------
Playlist of Stock ideas : https://youtube.com/playlist?list=PLS...
For Education Purposes Only
--------------------------------------------------------------------------------------

Who we are :
PA Wealth is an Investment Services Group having its head office in Ludhiana, Punjab and branch office in Gurugram/Gurgaon. PA Wealth's team has its core competence in Equity Research Analysis & Portfolio Management. The team is engaged in planning and handling customized, unconflicted investments for Retail and HNI clients. The team provides Professional Investment services for investments in Indian equities & debt instruments to Individuals, corporates and family office